Heterogeneity of anti-PR3 associated disease in Hong Kong

Postgraduate Medical Journal

Volumn 76, Issue 895, 2000, Pages 287-288

  Lee, Shui Shan ^a   Lawton, John W M ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

ANCA; Antineutrophil cytoplasm antibody; Proteinase 3 (PR3); Wegener's granulomatosus

Indexed keywords

MYELOBLASTIN; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL RESEARCH; DISEASE ASSOCIATION; FEMALE; GENETIC HETEROGENEITY; HONG KONG; HUMAN; HUMAN CELL; MALE; MORBIDITY; POPULATION RESEARCH; SYSTEMIC VASCULITIS; UPPER RESPIRATORY TRACT INFECTION; WEGENER GRANULOMATOSIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CHINA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HONG KONG; HUMANS; MALE; MIDDLE AGED; MYELOBLASTIN; SERINE ENDOPEPTIDASES; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 0034002850     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.76.895.287     Document Type: Article

References (5)

1. Van der woude FJ, Rasmussen N, Labatto S, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosus. Lancet 1985;i:425-7.
2. Jennette JC, Falk RJ. Small vessel vasculitis. N Engl J Med 1997;337:1512-23.
3. Kallenberg CGM, Brouwen E, Weening JJ, et al. Antineutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int 1994;46:1-15.
4. Watt RA, Carruthers DM, Scott DGI. Epidemiology of systemic vasculitis: changing incidence or definition. Semin Arthritis Rheum 1995;25:28-34.
5. Lee SS, Lawton JWM. Antimyeloperoxidase antibody in Chinese patients in Hong Kong: a five year review. Hong Kong Medical Journal 1996;2:40-6.